D2 dopamine receptor antagonists (NIH/NINDS/NCATS/Columbia University)

N/A

Report date: 2025/06/11 10:52:17
NME

Base Information

Drug NameD2 dopamine receptor antagonists (NIH/NINDS/NCATS/Columbia University)
Drug Alias NameML-321MLS-6916
ClassificationSmall molecules
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Advancing Translational SciencesNational Institute Of Neurological Disorders And Stroke
Inactive CompaniesNational Institutes Of HealthColumbia University
Active IndicationsPsychotic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A